On Tuesday, Atyr Pharma Inc (NASDAQ: ATYR) was -2.91% drop from the session before settling in for the closing price of $0.75. A 52-week range for ATYR has been $0.64 – $7.29.
During the last 5-year period, the sales growth of Healthcare Sector giant was 34.28%. When this article was written, the company’s average yearly earnings per share was at 2.49%. With a float of $95.56 million, this company’s outstanding shares have now reached $97.99 million.
Atyr Pharma Inc (ATYR) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Atyr Pharma Inc stocks. The insider ownership of Atyr Pharma Inc is 2.48%, while institutional ownership is 63.38%. The most recent insider transaction that took place on Oct 08 ’25, was worth 612,437. In this transaction Director of this company bought 682,001 shares at a rate of $0.90, taking the stock ownership to the 1,095,024 shares. Before that another transaction happened on Oct 09 ’25, when Company’s Director bought 317,999 for $0.94, making the entire transaction worth $299,364. This insider now owns 1,413,023 shares in total.
Atyr Pharma Inc (ATYR) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.18 earnings per share (EPS) during the time that was better than consensus figure (set at -0.23) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.14% during the next five years compared to 34.28% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
You can see what Atyr Pharma Inc (ATYR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.93. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 373.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.83, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Looking closely at Atyr Pharma Inc (NASDAQ: ATYR), its last 5-days average volume was 2.02 million, which is a jump from its year-to-date volume of 1.65 million. As of the previous 9 days, the stock’s Stochastic %D was 28.20%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 1.44%, which indicates a significant decrease from 21.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0504 in the past 14 days, which was lower than the 0.1443 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7774, while its 200-day Moving Average is $3.0610. However, in the short run, Atyr Pharma Inc’s stock first resistance to watch stands at $0.7527. Second resistance stands at $0.7810. The third major resistance level sits at $0.8021. If the price goes on to break the first support level at $0.7033, it is likely to go to the next support level at $0.6822. Now, if the price goes above the second support level, the third support stands at $0.6539.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
There are 97,987K outstanding shares of the company, which has a market capitalization of 70.97 million. As of now, sales total 240 K while income totals -64,020 K. Its latest quarter income was 190 K while its last quarter net income were -25,740 K.
